{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:07:34Z","timestamp":1788286054516,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.amjms.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T09:01:52Z","timestamp":1523091712000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reduced Stroke After Transcatheter Patent Foramen Ovale Closure: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"356","author":[{"given":"Chikezie","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas Javed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Farhan","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2018.04.004_bib1","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.amjms.2018.04.004_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMp1700218","article-title":"Patent foramen ovale after cryptogenic stroke - assessing the evidence for closure","volume":"377","author":"Farb","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.amjms.2018.04.004_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","article-title":"Practice advisory: recurrent stroke with patent foramen ovale (update of practice parameter): report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"87","author":"Messe","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.amjms.2018.04.004_bib5","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","article-title":"Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials","volume":"67","author":"Kent","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.04.004_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","article-title":"Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis","volume":"6","author":"Khan","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjms.2018.04.004_bib10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ccd.25122","article-title":"A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events","volume":"82","author":"Pineda","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjms.2018.04.004_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjms.2018.04.004_bib12","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","article-title":"Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Rengifo-Moreno","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.04.004_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hlc.2013.12.003","article-title":"Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials","volume":"23","author":"Pandit","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.amjms.2018.04.004_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","article-title":"Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis","volume":"36","author":"Stortecky","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.04.004_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"Capodanno","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjms.2018.04.004_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009938.pub2","article-title":"Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack","author":"Li","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjms.2018.04.004_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","article-title":"Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials","volume":"22","author":"Nagaraja","year":"2013","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.amjms.2018.04.004_bib18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cjca.2014.05.004","article-title":"Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses","volume":"30","author":"Udell","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjms.2018.04.004_bib19","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","article-title":"Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"168","author":"Kwong","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjms.2018.04.004_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","article-title":"PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"169","author":"Ntaios","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjms.2018.04.004_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","article-title":"Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis","volume":"100","author":"Wolfrum","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjms.2018.04.004_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2013.11.027","article-title":"A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack","volume":"337","author":"Chen","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.amjms.2018.04.004_bib23","doi-asserted-by":"crossref","first-page":"e004282","DOI":"10.1136\/bmjopen-2013-004282","article-title":"Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale","volume":"4","author":"Spencer","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.amjms.2018.04.004_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","article-title":"Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials","volume":"13","author":"Riaz","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.amjms.2018.04.004_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib28","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.amjms.2018.04.004_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.amjms.2018.04.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000352050","article-title":"The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping)","volume":"36","author":"Amarenco","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.amjms.2018.04.004_bib31","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"Easton","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjms.2018.04.004_bib32","first-page":"d5928","article-title":"The Cochrane Collaboration\u2032s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011"},{"key":"10.1016\/j.amjms.2018.04.004_bib33","article-title":"GD Cochrane Handbook of Systematic Reviews of Interventions 5.1.0 Part 2: General Methods for Cochrane Reviews","author":"Higgins","year":"2011","journal-title":"The Cochrane Collaboration"},{"key":"10.1016\/j.amjms.2018.04.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2017.06.015","article-title":"Patent foramen ovale closure to prevent secondary neurologic events","volume":"44","author":"Jasper","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjms.2018.04.004_bib35","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","article-title":"Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale","volume":"34","author":"Hornung","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2018.04.004_bib36","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jcin.2017.09.002","article-title":"Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials","volume":"10","author":"Mojadidi","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjms.2018.04.004_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1747-4949.2009.00336.x","article-title":"Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke","volume":"5","author":"Bonvini","year":"2010","journal-title":"Int J Stroke"},{"key":"10.1016\/j.amjms.2018.04.004_bib38","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jacc.2013.07.084","article-title":"Effect of percutaneous closure of patent foramen ovale on post-procedural arrhythmias","volume":"62","author":"Gaspardone","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2018.04.004_bib39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/STROKEAHA.114.007763","article-title":"Predictors of finding occult atrial fibrillation after cryptogenic stroke","volume":"46","author":"Favilla","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.amjms.2018.04.004_bib40","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918301423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962918301423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T04:24:24Z","timestamp":1536812664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962918301423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0002962918301423"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.04.004","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Stroke After Transcatheter Patent Foramen Ovale Closure: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}